GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
27.94
-0.71 (-2.48%)
At close: Aug 28, 2026, 4:00 PM EDT
28.16
+0.22 (0.79%)
After-hours: Aug 28, 2026, 7:52 PM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $1.92 billion as of August 28, 2026. Its market cap has increased by 126.84% in one year.
Market Cap
1.92B
Enterprise Value
1.56B
1-Year Change
126.84%
Ranking
Category
Stock Price
$27.94
ChartMarket Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $1.92B, an increase of 137.26%. That is a compound annual growth rate of 18.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 1.92B | 143.45% |
| Dec 31, 2025 | 787.77M | 116.30% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zymeworks | 2.01B |
| Maravai LifeSciences Holdings | 1.99B |
| Agios Pharmaceuticals | 1.99B |
| Generate Biomedicines | 1.97B |
| Forte Biosciences | 1.94B |
| Xencor | 1.94B |
| Lakefront Biotherapeutics NV | 1.89B |
| Immunocore Holdings | 1.89B |